Eris Lifesciences Limited (ERIS) Share Price & AI Investment Analysis
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitor. Track Eris Lifesciences Limited's live NSE:ERIS share price ₹1,271.20 (-1.86%), market cap ₹₹176B, P/E 27.1. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for ERIS — real-time NSE India stock intelligence.